Clinical Use of DPP-4 Inhibitors
US$ 20.05
glp-1 agonist alzheimer's Advances in Clinical and Experimental Medicine Novel Insights into the Roles
Description
doi: 10.1001/jama.2024.6586
The base-case analyses demonstrate that, when focusing solely on their cardiovascular benefits, GLP-1 RAs were not cost-effective in either the total or secondary prevention populations
N Engl J Med 345(12):861869 Moorhead JF, Brunton C, Varghese Z (1997) Glomerular atherosclerosis
Heart failure with preserved ejection fraction: everything the clinician needs to know
As earlier demonstrated, most of the patients among included studies were women, as it is known that more women than men seek treatment for obesity [78]
Besides, a novel GLP-1/GIP receptor agonist DA5-CH could reverse STZ-induced working memory and spatial memory impairments in rats (79)
